Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 20,591 | 20,450 | 21,774 | 24,556 | 21,970 |
| Cost of Goods | 8,570 | 8,917 | 9,590 | 10,545 | 9,205 |
| Gross Profit | 12,021 | 11,533 | 12,184 | 14,011 | 12,765 |
| Operating Expenses | 12,394 | 13,269 | 62,442 | 14,545 | 14,844 |
| Operating Income | 197 | -819 | -49,668 | 11 | -1,874 |
| Interest Expense | 966 | 791 | 802 | 853 | 856 |
| Other Income | -365 | -644 | -324 | 1,432 | -1,761 |
| Pre-tax Income | -1,134 | -2,254 | -50,794 | 590 | -4,491 |
| Income Tax | 97 | 28 | -454 | 572 | 311 |
| Net Income Continuous | -1,231 | -2,282 | -50,340 | 18 | -4,802 |
| Net Income | $-1,231 | $-2,282 | $-50,340 | $18 | $-4,802 |
| EPS Basic Total Ops | -0.03 | -0.05 | -1.14 | 0.01 | -0.11 |
| EPS Basic Continuous Ops | -0.03 | -0.05 | -1.14 | 0.00 | -0.11 |
| EPS Diluted Total Ops | -0.03 | -0.05 | -1.14 | 0.01 | -0.11 |
| EPS Diluted Continuous Ops | -0.03 | -0.05 | -1.14 | 0.00 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.02 | -0.02 | 0.04 | -0.05 |
| EBITDA(a) | $1,878 | $1,007 | $69 | $1,869 | $30 |